NCT02776644View on ClinicalTrials.gov

Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

CompletedOBSERVATIONAL

Enrollment

1,349

Participants

Timeline

Start Date

October 15, 2016

Primary Completion Date

December 30, 2017

Study Completion Date

December 30, 2017

Conditions

Renal Cell Carcinoma

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT02776644 - Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan | Biotech Hunter | Biotech Hunter